Latest news
Loading news…
Syndax Pharmaceuticals focuses on developing an HDAC inhibitor for solid tumors and hematological tumors.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
204
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Waltham, Massachusetts, United States
Key People at Syndax Pharmaceuticals
Chief Executive Officer
Chief Scientific Officer and Founder
General Counsel and Secretary
Director, Pharmaceutical Development and Manufacturing
Chief Financial Officer
Head of Research and Development and Chief Medical Officer
Chief Commercial Officer
204
professional contacts at Syndax Pharmaceuticals
Contact execs at Syndax Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Syndax Pharmaceuticals
Loading news…
FAQs about Syndax Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.